Clinical Trial Update: Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer. [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing capecitabine to bolus 5-FU with radiotherapy as neoadjuvant treatment for rectal cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Bolus 5-FU (5-fluorouracil (bolus))
• Capecitabine (capecitabine)

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Rectal Neoplasm Malignant | Phase 2, Phase 3 | Status: COMPLETED